CYDECTIN TRICLAMOX 1 MG/ML + 50 MG/ML ORAL SOLUTION FOR SHEEP

Kraj: Irlandia

Język: angielski

Źródło: HPRA (Health Products Regulatory Authority)

Składnik aktywny:

MOXIDECTIN, TRICLABENDAZOLE

Dostępny od:

Zoetis Ireland Limited

Kod ATC:

QP54AB52

INN (International Nazwa):

MOXIDECTIN, TRICLABENDAZOLE

Dawkowanie:

1/50

Forma farmaceutyczna:

Oral Solution

Typ recepty:

LM: Licensed Merchant as defined in relevant national legislation

Grupa terapeutyczna:

Ovine

Dziedzina terapeutyczna:

moxidectin, combinations

Wskazania:

Endectoparasiticides

Status autoryzacji:

Authorised

Data autoryzacji:

2013-12-09

Charakterystyka produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
3 PHARMACEUTICAL FORM
Oral solution.
A clear yellow to brown liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep.
ACTIVE SUBSTANCES
Moxidectin
1.0
mg
Triclabendazole
50.0 mg
EXCIPIENTS
Benzyl alcohol (E1519)
40.0 mg
Butylhydroxytoluene (E321)
1.0
mg
For the full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_4_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_5_
_0_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mixed nematode and fluke infections, caused by
moxidectin and triclabendazole sensitive strains
of:
The product has a persistent efficacy and protects sheep against
infection or re-infection with the following parasites for
the period indicated:
Clinical trials, after experimental and natural infection, have shown
that the product is effective against certain
benzimidazole resistant strains of:
_Haemonchus contortus_
_Teladorsagia circumcincta_
_Trichostrongylus colubriformis_
_Cooperia curticei_
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance(s) or
to any of
the excipient(s).
Parasite
ADULT STAGE
L4
INHIBITED STAGES
NEMATODES
GASTRO-INTESTINAL NEMATODES:
_Haemonchus contortus_
_Teladorsagia